New Age Alpha Advisors LLC bought a new position in shares of HealthEquity, Inc. (NASDAQ:HQY – Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 2,591 shares of the company’s stock, valued at approximately $249,000.
Other large investors also recently modified their holdings of the company. Norges Bank bought a new position in shares of HealthEquity in the fourth quarter valued at approximately $74,701,000. Caisse Des Depots ET Consignations bought a new stake in shares of HealthEquity in the 4th quarter worth $1,660,000. Artisan Partners Limited Partnership purchased a new stake in shares of HealthEquity in the fourth quarter valued at about $24,568,000. Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in shares of HealthEquity by 31.7% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,974 shares of the company’s stock valued at $192,000 after purchasing an additional 475 shares in the last quarter. Finally, Meiji Yasuda Asset Management Co Ltd. purchased a new position in HealthEquity during the fourth quarter worth about $205,000. 99.55% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
Several research firms have recently issued reports on HQY. JMP Securities upped their target price on HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a report on Tuesday, December 10th. Royal Bank of Canada upped their price objective on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research note on Tuesday, December 10th. Mizuho began coverage on shares of HealthEquity in a research report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price target for the company. The Goldman Sachs Group lowered their price objective on shares of HealthEquity from $107.00 to $94.00 and set a “neutral” rating on the stock in a research report on Thursday, March 27th. Finally, Raymond James upgraded HealthEquity from an “outperform” rating to a “strong-buy” rating and dropped their price objective for the company from $120.00 to $115.00 in a research note on Tuesday, March 25th. One investment analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $112.58.
HealthEquity Stock Performance
Shares of HQY opened at $88.74 on Thursday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The stock has a market capitalization of $7.68 billion, a price-to-earnings ratio of 81.41, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $115.59. The stock’s 50-day simple moving average is $102.66 and its 200 day simple moving average is $96.30.
Insider Activity
In related news, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the sale, the director now owns 78,219 shares of the company’s stock, valued at approximately $8,704,992.51. This trade represents a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 2.20% of the stock is owned by company insiders.
About HealthEquity
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Read More
- Five stocks we like better than HealthEquity
- 3 REITs to Buy and Hold for the Long Term
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- Roth IRA Calculator: Calculate Your Potential Returns
- The 3 Most Talked About Investments on WallStreetBets Right Now
- With Risk Tolerance, One Size Does Not Fit All
- Analyst Targets Signal More Growth in CrowdStrike Stock
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.